Aarti Pharmalabs Statistics
Total Valuation
NSE:AARTIPHARM has a market cap or net worth of INR 85.16 billion. The enterprise value is 88.73 billion.
Market Cap | 85.16B |
Enterprise Value | 88.73B |
Important Dates
The next estimated earnings date is Tuesday, October 28, 2025.
Earnings Date | Oct 28, 2025 |
Ex-Dividend Date | Sep 15, 2025 |
Share Statistics
NSE:AARTIPHARM has 90.64 million shares outstanding. The number of shares has increased by 0.05% in one year.
Current Share Class | 90.64M |
Shares Outstanding | 90.64M |
Shares Change (YoY) | +0.05% |
Shares Change (QoQ) | -0.04% |
Owned by Insiders (%) | 29.03% |
Owned by Institutions (%) | 20.55% |
Float | 47.96M |
Valuation Ratios
The trailing PE ratio is 31.98.
PE Ratio | 31.98 |
Forward PE | n/a |
PS Ratio | 4.38 |
PB Ratio | 4.28 |
P/TBV Ratio | 4.51 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 33.30 |
EV / Sales | 4.56 |
EV / EBITDA | 19.20 |
EV / EBIT | 23.86 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.21 |
Debt / EBITDA | 0.89 |
Debt / FCF | n/a |
Interest Coverage | 12.95 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | 10.51% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 9.00M |
Profits Per Employee | 1.23M |
Employee Count | 2,162 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:AARTIPHARM has paid 860.15 million in taxes.
Income Tax | 860.15M |
Effective Tax Rate | 24.40% |
Stock Price Statistics
The stock price has increased by +42.60% in the last 52 weeks. The beta is -0.50, so NSE:AARTIPHARM's price volatility has been lower than the market average.
Beta (5Y) | -0.50 |
52-Week Price Change | +42.60% |
50-Day Moving Average | 888.17 |
200-Day Moving Average | 774.20 |
Relative Strength Index (RSI) | 64.75 |
Average Volume (20 Days) | 332,344 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:AARTIPHARM had revenue of INR 19.46 billion and earned 2.66 billion in profits. Earnings per share was 29.38.
Revenue | 19.46B |
Gross Profit | 9.75B |
Operating Income | 3.74B |
Pretax Income | 3.52B |
Net Income | 2.66B |
EBITDA | 4.64B |
EBIT | 3.74B |
Earnings Per Share (EPS) | 29.38 |
Balance Sheet
The company has 562.06 million in cash and 4.13 billion in debt, giving a net cash position of -3.57 billion or -39.38 per share.
Cash & Cash Equivalents | 562.06M |
Total Debt | 4.13B |
Net Cash | -3.57B |
Net Cash Per Share | -39.38 |
Equity (Book Value) | 19.90B |
Book Value Per Share | 219.62 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 50.11%, with operating and profit margins of 19.20% and 13.69%.
Gross Margin | 50.11% |
Operating Margin | 19.20% |
Pretax Margin | 18.11% |
Profit Margin | 13.69% |
EBITDA Margin | 23.84% |
EBIT Margin | 19.20% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 0.54%.
Dividend Per Share | 5.00 |
Dividend Yield | 0.54% |
Dividend Growth (YoY) | 66.67% |
Years of Dividend Growth | 2 |
Payout Ratio | n/a |
Buyback Yield | -0.05% |
Shareholder Yield | 0.49% |
Earnings Yield | 3.13% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |